Rosai-Dorfman disease (RDD): management
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Rosai-Dorfman disease (RDD): management. Uniformly enhancing dural-based lesions, These may demonstrate a dural tail. Fully referenced neurology checklist.
Magnetic resonance imaging (MRI) brain
- Uniformly enhancing dural-based lesions
- These may demonstrate a dural tail
- There may be associated vasogenic oedema
- Parenchymal lesions may occur
Cerebrospinal fluid (CSF) analysis
Locked: subscribe to see this section.
Blood investigations
Locked: subscribe to see this section.
Other investigations
Locked: subscribe to see this section.
Treatment
Locked: subscribe to see this section.
Synonyms
Locked: subscribe to see this section.
References
- Varrassi M, Corridore A, Tommasino E, et al. MR imaging of cerebral involvement of Rosai-Dorfman disease: a single-centre experience with review of the literature. Radiol Med 2021; 126:89-98.
- Aljohani HT, Robin S. A rare case of isolated intracranial Rosai-Dorfman disease mimicking optic nerve meningioma: a case report and literature review. Asian J Neurosurg 2018; 13:845-847.
- Gilani K, Kuntz S, Munoz DG, Schneider R. Pearls & Oy-sters: Rosai-Dorfman disease of the central nervous system. Neurology 2021 (Online ahead of print).
- Abla O, Jacobsen E, Picarsic J, et al. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood 2018; 131:2877-2890.
- Wei C, Zhou DB. Long-time remission of laryngeal Rosai-Dorfman disease with thalidomide: a report of three cases. Hematology 2021; 26:552-555.
- And 4 more. Subscribe to see the full list
